These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32283957)

  • 1. HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies.
    Zhong GC; Huang SQ; Peng Y; Wan L; Wu YQ; Hu TY; Hu JJ; Hao FB
    Eur J Prev Cardiol; 2020 Jul; 27(11):1187-1203. PubMed ID: 32283957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very high high-density lipoprotein cholesterol is associated with increased all-cause mortality in South Koreans.
    Oh IH; Hur JK; Ryoo JH; Jung JY; Park SK; Yang HJ; Choi JM; Jung KW; Won YJ; Oh CM
    Atherosclerosis; 2019 Apr; 283():43-51. PubMed ID: 30776703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.
    Moradi H; Streja E; Kashyap ML; Vaziri ND; Fonarow GC; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2014 Aug; 29(8):1554-62. PubMed ID: 24574544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study.
    Ko DT; Alter DA; Guo H; Koh M; Lau G; Austin PC; Booth GL; Hogg W; Jackevicius CA; Lee DS; Wijeysundera HC; Wilkins JT; Tu JV
    J Am Coll Cardiol; 2016 Nov; 68(19):2073-2083. PubMed ID: 27810046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein cholesterol and causes of death in chronic kidney disease.
    Navaneethan SD; Schold JD; Walther CP; Arrigain S; Jolly SE; Virani SS; Winkelmayer WC; Nally JV
    J Clin Lipidol; 2018; 12(4):1061-1071.e7. PubMed ID: 29699917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between risk of overall mortality, cause-specific mortality and level of inflammatory factors with extremely low and high high-density lipoprotein cholesterol levels among American adults.
    Mazidi M; Mikhailidis DP; Banach M
    Int J Cardiol; 2019 Feb; 276():242-247. PubMed ID: 30473336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study.
    Hirata A; Sugiyama D; Watanabe M; Tamakoshi A; Iso H; Kotani K; Kiyama M; Yamada M; Ishikawa S; Murakami Y; Miura K; Ueshima H; Okamura T;
    J Clin Lipidol; 2018; 12(3):674-684.e5. PubMed ID: 29506864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The U Shaped Relationship Between High-Density Lipoprotein Cholesterol and All-Cause or Cause-Specific Mortality in Adult Population.
    Huang YQ; Liu XC; Lo K; Liu L; Yu YL; Chen CL; Huang JY; Feng YQ; Zhang B
    Clin Interv Aging; 2020; 15():1883-1896. PubMed ID: 33061337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated measures of extremely high levels of high-density lipoprotein cholesterol and subsequent all-cause mortality and cardiovascular events: A longitudinal study.
    Kobayashi D; Noto H; Shimbo T; Ino T; Osugi Y; Takahashi O; Asai K
    Atherosclerosis; 2019 Sep; 288():17-25. PubMed ID: 31295627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of Isolated Low High-Density Lipoprotein Cholesterol to Mortality and Cardiorespiratory Fitness (from the Henry Ford Exercise Testing Project [FIT Project]).
    Whelton SP; Dardari Z; Handy Marshall C; Ahmed H; Brawner CA; Ehrman JK; Keteyian SJ; Mallah MA; Blaha MJ
    Am J Cardiol; 2019 May; 123(9):1429-1434. PubMed ID: 30827489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population.
    Okamura T; Hayakawa T; Kadowaki T; Kita Y; Okayama A; Ueshima H;
    Atherosclerosis; 2006 Jan; 184(1):143-50. PubMed ID: 15913635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Density Lipoprotein Cholesterol and Mortality: Too Much of a Good Thing?
    Hamer M; O'Donovan G; Stamatakis E
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):669-672. PubMed ID: 29326314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of lipids and lipoprotein level with total mortality and mortality caused by cardiovascular and cancer diseases (Poland and United States collaborative study on cardiovascular epidemiology).
    Rywik SL; Manolio TA; Pajak A; Piotrowski W; Davis CE; Broda GB; Kawalec E
    Am J Cardiol; 1999 Sep; 84(5):540-8. PubMed ID: 10482152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary intake of total, animal, and plant proteins and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of prospective cohort studies.
    Naghshi S; Sadeghi O; Willett WC; Esmaillzadeh A
    BMJ; 2020 Jul; 370():m2412. PubMed ID: 32699048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
    Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
    BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-response meta-analysis to evaluate the relationship between high-density lipoprotein cholesterol and all-cause and cardiovascular disease mortality.
    Liu L; Han M; Qie R; Li Q; Zhang X; Zhang J; Zhan S; Zhang L; Xu Z; Zhang C; Hong F
    J Endocrinol Invest; 2022 Mar; 45(3):551-562. PubMed ID: 34676492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan.
    Hirata T; Sugiyama D; Nagasawa SY; Murakami Y; Saitoh S; Okayama A; Iso H; Irie F; Sairenchi T; Miyamoto Y; Yamada M; Ishikawa S; Miura K; Ueshima H; Okamura T;
    Eur J Epidemiol; 2017 Jul; 32(7):547-557. PubMed ID: 27709448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Lipid-Lowering Therapy on Mortality According to the Baseline Non-HDL Cholesterol Level: A Meta-Analysis.
    Masson W; Lobo M; Siniawski D; Molinero G; Huerín M; Nogueira JP
    High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):263-272. PubMed ID: 31313082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Density Lipoprotein Cholesterol and All-Cause and Cause-Specific Mortality Among the Elderly.
    Li ZH; Lv YB; Zhong WF; Gao X; Byers Kraus V; Zou MC; Zhang XR; Li FR; Yuan JQ; Shi XM; Wu XB; Mao C
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3370-3378. PubMed ID: 30869791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.